Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

Michael PennickBiosciences Department, Shire Pharmaceutical Development Ltd, Basingstoke, UKAbstract: These studies investigated the absorption and metabolic conversion of lisdexamfetamine dimesylate (LDX), a prodrug stimulant that requires conversion to d-amphetamine for activity. Oral absorption o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Michael Pennick
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/50dcc49742e546ef94b5dfbec870a8c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!